Ebola’s Congo outbreak accelerates beyond response capacity

Jul 20 - Jul 24across 5 daysImpact

Cyclospora spreads without a source

The Cyclospora outbreak expanded from more than 1,400 infections to nine states, while investigators still lacked a definitive source. The episode intensified scrutiny of produce traceability, sanitation, and the limits of the response.

11 stories20 Mon 21 Tue 22 Wed 23 Thu 24 Fri

Jul 22 - Jul 26across 4 daysImpact

Ebola accelerates across Congo border

Congo’s Ebola outbreak grew from more than 1,000 deaths to 1,405 deaths and 3,200 infections, while conflict, displacement, and weak response capacity obstructed containment. Uganda rebuilt border surveillance and response measures as spillover risk increased, and findings suggested an existing vaccine might offer some protection.

10 stories22 Wed 23 Thu 24 Fri 25 Sat 26 Sun

Jul 20 - Jul 26across 6 daysImpact

GLP-1 demand meets access limits

GLP-1 competition widened from advertising disputes and new efficacy data to concerns about hair loss, recurring insurance costs, cold-chain capacity, and retail effects. The week shifted the debate from clinical promise toward affordability, logistics, and the practical limits of broad access.

15 stories20 Mon 21 Tue 22 Wed 23 Thu 24 Fri 25 Sat 26 Sun

Jul 22 - Jul 24across 3 daysImpact

Peptide compounding challenges evidence rules

Regulators moved toward allowing compounding of several unapproved peptides despite limited safety and effectiveness evidence, while rejecting at least one substance. The split sharpened the conflict between consumer demand for access and conventional evidentiary standards.

8 stories22 Wed 23 Thu 24 Fri

Jul 20 - Jul 23across 3 daysImpact

Legionnaires exposes city oversight gaps

New York City’s Legionnaires’ outbreak grew from four to five deaths and 82 illnesses, with live Legionella found in 34 cooling towers. Vacant inspection positions, noncompliant buildings, and the city’s rush to recruit inspectors revealed weaknesses in continuous oversight.

9 stories20 Mon 21 Tue 22 Wed 23 Thu

Jul 21 - Jul 22across 2 daysImpact

HIV aid cuts close treatment sites

US funding cuts disrupted HIV clinics and medicine access across multiple countries, with later findings documenting the closure of roughly 1,700 treatment sites. The interruptions threaten treatment continuity, prevention progress, and resistance control.

2 stories21 Tue 22 Wed

Jul 21 - Jul 22across 2 daysImpact

Medicaid payments held over fraud inquiry

The administration continued deferring more than $1 billion in Medicaid payments to California and Minnesota over suspected fraud and noncompliance. The delay placed state budgets, provider reimbursements, and care networks under continuing strain.

2 stories21 Tue 22 Wed

Jul 22 - Jul 24across 2 daysImpact

Generic tariffs threaten medicine supply

The administration proposed steep future tariffs on imported generic drugs to encourage US manufacturing, while a pharmaceutical executive warned that the policy could raise prices. Uncertainty over implementation added to concerns about shortages and supply stability.

4 stories22 Wed 23 Thu 24 Fri

Week’s Recap

Stories that evolved over the week.